MXPA02003884A - Metodos de sintetizar asimetricamente enantiomeros de casodex, sus derivados e intermediarios de los mismos. - Google Patents

Metodos de sintetizar asimetricamente enantiomeros de casodex, sus derivados e intermediarios de los mismos.

Info

Publication number
MXPA02003884A
MXPA02003884A MXPA02003884A MXPA02003884A MXPA02003884A MX PA02003884 A MXPA02003884 A MX PA02003884A MX PA02003884 A MXPA02003884 A MX PA02003884A MX PA02003884 A MXPA02003884 A MX PA02003884A MX PA02003884 A MXPA02003884 A MX PA02003884A
Authority
MX
Mexico
Prior art keywords
compound
formula
derivatives
casodexreg
acylanalides
Prior art date
Application number
MXPA02003884A
Other languages
English (en)
Spanish (es)
Inventor
Ekwuribe Nnochiri
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of MXPA02003884A publication Critical patent/MXPA02003884A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MXPA02003884A 1999-10-19 2000-10-18 Metodos de sintetizar asimetricamente enantiomeros de casodex, sus derivados e intermediarios de los mismos. MXPA02003884A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16041299P 1999-10-19 1999-10-19
PCT/US2000/041233 WO2001028990A2 (en) 1999-10-19 2000-10-18 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof

Publications (1)

Publication Number Publication Date
MXPA02003884A true MXPA02003884A (es) 2004-09-06

Family

ID=22576803

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02003884A MXPA02003884A (es) 1999-10-19 2000-10-18 Metodos de sintetizar asimetricamente enantiomeros de casodex, sus derivados e intermediarios de los mismos.

Country Status (18)

Country Link
US (2) US6583306B1 (cg-RX-API-DMAC7.html)
EP (1) EP1222165A2 (cg-RX-API-DMAC7.html)
JP (1) JP5112583B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020091047A (cg-RX-API-DMAC7.html)
CN (1) CN1409702A (cg-RX-API-DMAC7.html)
AU (1) AU1968601A (cg-RX-API-DMAC7.html)
BR (1) BR0014889A (cg-RX-API-DMAC7.html)
CA (1) CA2387570A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20021340A3 (cg-RX-API-DMAC7.html)
HK (1) HK1048298A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0203785A2 (cg-RX-API-DMAC7.html)
IL (2) IL149056A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02003884A (cg-RX-API-DMAC7.html)
NO (1) NO20021831L (cg-RX-API-DMAC7.html)
NZ (1) NZ518392A (cg-RX-API-DMAC7.html)
PL (1) PL354620A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001028990A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200202947B (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US7759520B2 (en) 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6995284B2 (en) 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US6998500B2 (en) 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US6838484B2 (en) 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7026500B2 (en) 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US6737550B2 (en) * 2001-06-13 2004-05-18 Biogal Gryogyszergyar Rt. Process for preparing rac-bicalutamide and its intermediates
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
PT1463497E (pt) 2001-12-06 2011-12-20 Gtx Inc Tratamento do desgaste muscular com moduladores selectivos do receptor de androgénios
US6740770B2 (en) 2001-12-13 2004-05-25 Sumika Fine Chemicals Co., Ltd. Crystal of bicalutamide and production method thereof
CA2689080C (en) 2002-02-07 2011-07-05 University Of Tennessee Research Foundation Treating benign prostate hyperplasia with sarms
JP5113979B2 (ja) 2002-02-28 2013-01-09 ユニバーシティ オブ テネシー リサーチ ファウンデーション 複数置換の選択的アンドロゲンレセプタ修飾因子及びその使用方法
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
WO2003074450A2 (en) 2002-02-28 2003-09-12 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
US7803970B2 (en) 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
DE10222104A1 (de) 2002-05-17 2003-12-04 Helm Ag Verfahren zur Herstellung von N-(4'-Cyano-3'-trifluormethyl)-3-(4"-fluorphenylsulfonyl)-2-hydroxy-2-methylpropionamid
US7741371B2 (en) 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
AU2003241583B2 (en) 2002-06-17 2009-05-21 University Of Tennessee Research Foundation N-bridged selective androgen receptor modulators and methods of use thereof
DE50213170D1 (de) * 2002-09-04 2009-02-12 Fraunhofer Ges Forschung Verwendung eines Mittel zur Therapie der Herzhypertrophie
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms
US6818766B2 (en) 2002-10-02 2004-11-16 Synthon Bv Process for making bicalutamide and intermediates thereof
EP1562594A4 (en) 2002-10-15 2008-12-17 Univ Tennessee Res Foundation SELECTIVE ANDROGEN RECEPTOR MODULATORS WITH METHYLENE BRIDGES AND METHOD OF USE THEREOF
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
JP4322621B2 (ja) 2003-10-16 2009-09-02 住友化学株式会社 4’−シアノ−3−[(4−フルオロフェニル)スルホニル]−2−ヒドロキシ−2−メチル−3’−トリフルオロメチルプロピオンアニリドの製造方法
AU2004305061A1 (en) 2003-12-16 2005-07-07 Gtx, Inc. Prodrugs of selective androgen receptor modulators and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
WO2008013791A2 (en) * 2006-07-24 2008-01-31 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
AU2007287070C1 (en) 2006-08-24 2013-02-14 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
WO2010116342A2 (en) * 2009-04-10 2010-10-14 Consiglio Nazionale Delle Ricerche Non-steroidal compounds for androgen receptor modulation
ITBO20090236A1 (it) * 2009-04-10 2010-10-11 Consiglio Nazionale Ricerche Procedimento per la sintesi di composti per il trattamento del tumore alla prostata
WO2011008543A2 (en) * 2009-06-29 2011-01-20 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
CN103539710A (zh) * 2012-07-02 2014-01-29 国药一心制药有限公司 一种(r)-比卡鲁胺的合成方法
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
EP3733170A1 (en) 2012-07-13 2020-11-04 Oncternal Therapeutics, Inc. A method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US12685719B2 (en) 2012-07-13 2026-07-21 University Of Tennessee Research Foundation Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3372965D1 (en) 1982-07-23 1987-09-17 Ici Plc Amide derivatives
GB8617652D0 (en) 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
WO1998055153A1 (en) 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US6186674B1 (en) * 1998-09-15 2001-02-13 Lucent Technologies, Inc. Optical sub-assembly package mount
US6252762B1 (en) * 1999-04-21 2001-06-26 Telcordia Technologies, Inc. Rechargeable hybrid battery/supercapacitor system
US6331992B1 (en) * 2000-04-07 2001-12-18 Stratos Lightwave, Inc. Small format optical subassembly
US6459842B1 (en) * 2000-12-13 2002-10-01 Teraconnect, Inc. Packaging system for two-dimensional optoelectronic arrays
US6821032B2 (en) * 2002-05-28 2004-11-23 Intel Corporation Methods of sealing electronic, optical and electro-optical packages and related package and substrate designs

Also Published As

Publication number Publication date
IL149056A (en) 2011-05-31
WO2001028990A2 (en) 2001-04-26
IL149056A0 (en) 2002-11-10
NO20021831D0 (no) 2002-04-18
US6583306B1 (en) 2003-06-24
AU1968601A (en) 2001-04-30
NZ518392A (en) 2004-02-27
JP5112583B2 (ja) 2013-01-09
NO20021831L (no) 2002-06-19
US7022869B2 (en) 2006-04-04
KR20020091047A (ko) 2002-12-05
US20040030130A1 (en) 2004-02-12
HUP0203785A2 (hu) 2003-04-28
PL354620A1 (en) 2004-02-09
HK1048298A1 (zh) 2003-03-28
CN1409702A (zh) 2003-04-09
ZA200202947B (en) 2003-09-23
CZ20021340A3 (cs) 2002-08-14
WO2001028990A3 (en) 2001-09-07
JP2003512351A (ja) 2003-04-02
BR0014889A (pt) 2002-12-31
EP1222165A2 (en) 2002-07-17
CA2387570A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
WO2001028990A3 (en) Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof
HK1048299A1 (zh) 在合成基本纯比卡鲁胺(bicalutamide)过程中的中间产物的分辨
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
BG103980A (en) 4-phenylpiperidine compounds
HUP9903836A2 (hu) Új eljárás Cox-2 inhibítor hatású fenil-szubsztituált 2(5H)-furanonok előállítására
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
GB9711650D0 (en) Compounds useful in therapy
WO2005007625A3 (en) Heterocyclic amides with anti-tuberculosis activity
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
GB0216539D0 (en) Compositions
GB1491510A (en) 1-nitrophenylquinazoline-2,4(1h,3h)-diones
CA2151149A1 (en) Novel ring opening monomers
PT1447400E (pt) Composto bicíclico
WO1999009965A3 (en) Anti-inflammatory agent
WO1999023092A3 (en) 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
DE60230781D1 (en) Reverse hydroxamsäurederivate
CA2308315A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
AU574075B2 (en) Trisazolo(2,3-c)(1,3)benzodiazepines
KR860000271A (ko) 치환된 페닐술포닐우레아의 제조방법
KR830007667A (ko) 4-아미노이미다졸로[4,5-c]리파마이신 SV 또는 S의 N,N-디 치환된 유도체의 제조방법
KR840006339A (ko) 3-아릴-7-클로로-3,4-디히드로아크리딘-1,9(2h,10h)-디온-1-옥심 및-1-히드라존 유도체의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
IL152696A0 (en) Process for the preparation of pesticidal compounds
BR0312773A (pt) Método para produzir um composto altamente puro
TW324005B (en) Process of making N-alkyl acetamide

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights